- Insider Transactions : 6-Jan-06 PAUKEN, THOMAS W.
Director 5,000 Indirect Purchase at $2.072 per share. $10,360
6-Jan-06 BUCKLEY, JOHN J.
Director 30,000 Direct Purchase at $2.18 - $2.23 per share. $66,0002
About Hemispherx Biopharma
Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders....